We're teaming up with the International PNH Interest Group to improve care for people with Paroxysmal Nocturnal Hemoglobinuria (PNH) in low-resource countries. PNH is a rare, debilitating blood disease that requires frequent blood transfusions & poses high risk without treatment.
Join our PNH Awareness Campaign! 🌟 From Sept 6 to Oct 12, let's raise awareness about Paroxysmal Nocturnal Hemoglobinuria. Share our posts with #PNHAwareness2024, join discussions, and support those affected. Together, we can make a difference! 💪 #DidYouKnow#TreatingPNH
Fantastic poster session yesterday. 🎉 Congratulations 🎉 to @AlexandraCPike and the team at Leeds, and to @AlexLubin6 & @bethpay and the team at UCL on their ASH Abstract Achievement Awards - a double win for Blood Cancer UK funded grants! 🏆 #ASH23
Another very nice selected abstract evaluating disease burden and it’s implications for patients with #pnh within a UK-F-G consortium including QLQ-AA/PNH54 developed by @UniklinikAachen with strong support and collaboration @lichterzellen and @AAundPNHeV
Congratulations to @UniversityLeeds' Prof Peter Hillmen for being awarded the Ernest Beutler Lecture and Prize, for 30 years of research on paroxysmal nocturnal hemoglobinuria. Great stuff! https://t.co/hgwWBxwCZY
Very proud to say that that the recent Leeds Covid vaccination study, funded by The Aplastic Anaemia Trust, has been published in The Lancet Haematology. https://t.co/sr6SAaLmlk @TheLancetHaem
Congratulations to Dr Pike for her recent publication assessing SARS-CoV-2 antibody response to vaccine in patients with aplastic anemia and PNH; thank you to the patients for their participation
https://t.co/9C2M8shECv